Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pril-series Intermediate Market Report 2019, Competitive Landscape, Trends and Opportunities

  • MAI3216005
  • 128 Pages
  • July 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Pril-series Intermediate market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Pril-series Intermediate market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Pril-series Intermediate market.

Major players in the global Pril-series Intermediate market include:

Esteve Quimica

Cemelog-BRS

Arrow Pharmaceuticals

Strides Shasun Limited

Pharmanova

Lek

Aurobindo Pharma Limited

Sanofi-Aventis

Zhejiang Huahai Pharmaceutical Co., Ltd.

Westfield Pharma

Santa Cruz Biotechnology

Opsonin Pharma Limited

ScinoPharm Taiwan

Mylan LLC

Primetime

Novartis

Lupin Ltd

LGM Pharma

Canagen Pharmaceuticals Inc

Shasun Chemicals and Drugs Ltd

Jiangsu Wisdom Pharmaceutical

Genesisny

Hemofarm

Sun Pharma

Signa S.A. de C.V.

Farmhispania

King Pharmaceuticals

Aarti Industries Ltd

On the basis of types, the Pril-series Intermediate market is primarily split into:

Benazepril

Cilazapril

Quinapril

Ramipril

On the basis of applications, the market covers:

Table

Capsule

Others

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Pril-series Intermediate market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Pril-series Intermediate market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Pril-series Intermediate industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Pril-series Intermediate market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Pril-series Intermediate, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Pril-series Intermediate in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Pril-series Intermediate in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Pril-series Intermediate. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Pril-series Intermediate market, including the global production and revenue forecast, regional forecast. It also foresees the Pril-series Intermediate market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

Table of Contents

1 Pril-series Intermediate Market Overview

1.1 Product Overview and Scope of Pril-series Intermediate

1.2 Pril-series Intermediate Segment by Type

1.2.1 Global Pril-series Intermediate Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Benazepril

1.2.3 The Market Profile of Cilazapril

1.2.4 The Market Profile of Quinapril

1.2.5 The Market Profile of Ramipril

1.3 Global Pril-series Intermediate Segment by Application

1.3.1 Pril-series Intermediate Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Table

1.3.3 The Market Profile of Capsule

1.3.4 The Market Profile of Others

1.4 Global Pril-series Intermediate Market by Region (2014-2026)

1.4.1 Global Pril-series Intermediate Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3 Europe Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.1 Germany Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.2 UK Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.3 France Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.4 Italy Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.5 Spain Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.6 Russia Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.3.7 Poland Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.4 China Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.5 Japan Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.6 India Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.8 Central and South America Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Pril-series Intermediate Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Pril-series Intermediate Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Pril-series Intermediate (2014-2026)

1.5.1 Global Pril-series Intermediate Revenue Status and Outlook (2014-2026)

1.5.2 Global Pril-series Intermediate Production Status and Outlook (2014-2026)

2 Global Pril-series Intermediate Market Landscape by Player

2.1 Global Pril-series Intermediate Production and Share by Player (2014-2019)

2.2 Global Pril-series Intermediate Revenue and Market Share by Player (2014-2019)

2.3 Global Pril-series Intermediate Average Price by Player (2014-2019)

2.4 Pril-series Intermediate Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Pril-series Intermediate Market Competitive Situation and Trends

2.5.1 Pril-series Intermediate Market Concentration Rate

2.5.2 Pril-series Intermediate Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Esteve Quimica

3.1.1 Esteve Quimica Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Pril-series Intermediate Product Profiles, Application and Specification

3.1.3 Esteve Quimica Pril-series Intermediate Market Performance (2014-2019)

3.1.4 Esteve Quimica Business Overview

3.2 Cemelog-BRS

3.2.1 Cemelog-BRS Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Pril-series Intermediate Product Profiles, Application and Specification

3.2.3 Cemelog-BRS Pril-series Intermediate Market Performance (2014-2019)

3.2.4 Cemelog-BRS Business Overview

3.3 Arrow Pharmaceuticals

3.3.1 Arrow Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Pril-series Intermediate Product Profiles, Application and Specification

3.3.3 Arrow Pharmaceuticals Pril-series Intermediate Market Performance (2014-2019)

3.3.4 Arrow Pharmaceuticals Business Overview

3.4 Strides Shasun Limited

3.4.1 Strides Shasun Limited Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Pril-series Intermediate Product Profiles, Application and Specification

3.4.3 Strides Shasun Limited Pril-series Intermediate Market Performance (2014-2019)

3.4.4 Strides Shasun Limited Business Overview

3.5 Pharmanova

3.5.1 Pharmanova Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Pril-series Intermediate Product Profiles, Application and Specification

3.5.3 Pharmanova Pril-series Intermediate Market Performance (2014-2019)

3.5.4 Pharmanova Business Overview

3.6 Lek

3.6.1 Lek Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Pril-series Intermediate Product Profiles, Application and Specification

3.6.3 Lek Pril-series Intermediate Market Performance (2014-2019)

3.6.4 Lek Business Overview

3.7 Aurobindo Pharma Limited

3.7.1 Aurobindo Pharma Limited Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Pril-series Intermediate Product Profiles, Application and Specification

3.7.3 Aurobindo Pharma Limited Pril-series Intermediate Market Performance (2014-2019)

3.7.4 Aurobindo Pharma Limited Business Overview

3.8 Sanofi-Aventis

3.8.1 Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Pril-series Intermediate Product Profiles, Application and Specification

3.8.3 Sanofi-Aventis Pril-series Intermediate Market Performance (2014-2019)

3.8.4 Sanofi-Aventis Business Overview

3.9 Zhejiang Huahai Pharmaceutical Co., Ltd.

3.9.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Pril-series Intermediate Product Profiles, Application and Specification

3.9.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Pril-series Intermediate Market Performance (2014-2019)

3.9.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview

3.10 Westfield Pharma

3.10.1 Westfield Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Pril-series Intermediate Product Profiles, Application and Specification

3.10.3 Westfield Pharma Pril-series Intermediate Market Performance (2014-2019)

3.10.4 Westfield Pharma Business Overview

3.11 Santa Cruz Biotechnology

3.11.1 Santa Cruz Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Pril-series Intermediate Product Profiles, Application and Specification

3.11.3 Santa Cruz Biotechnology Pril-series Intermediate Market Performance (2014-2019)

3.11.4 Santa Cruz Biotechnology Business Overview

3.12 Opsonin Pharma Limited

3.12.1 Opsonin Pharma Limited Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Pril-series Intermediate Product Profiles, Application and Specification

3.12.3 Opsonin Pharma Limited Pril-series Intermediate Market Performance (2014-2019)

3.12.4 Opsonin Pharma Limited Business Overview

3.13 ScinoPharm Taiwan

3.13.1 ScinoPharm Taiwan Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Pril-series Intermediate Product Profiles, Application and Specification

3.13.3 ScinoPharm Taiwan Pril-series Intermediate Market Performance (2014-2019)

3.13.4 ScinoPharm Taiwan Business Overview

3.14 Mylan LLC

3.14.1 Mylan LLC Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Pril-series Intermediate Product Profiles, Application and Specification

3.14.3 Mylan LLC Pril-series Intermediate Market Performance (2014-2019)

3.14.4 Mylan LLC Business Overview

3.15 Primetime

3.15.1 Primetime Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Pril-series Intermediate Product Profiles, Application and Specification

3.15.3 Primetime Pril-series Intermediate Market Performance (2014-2019)

3.15.4 Primetime Business Overview

3.16 Novartis

3.16.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Pril-series Intermediate Product Profiles, Application and Specification

3.16.3 Novartis Pril-series Intermediate Market Performance (2014-2019)

3.16.4 Novartis Business Overview

3.17 Lupin Ltd

3.17.1 Lupin Ltd Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Pril-series Intermediate Product Profiles, Application and Specification

3.17.3 Lupin Ltd Pril-series Intermediate Market Performance (2014-2019)

3.17.4 Lupin Ltd Business Overview

3.18 LGM Pharma

3.18.1 LGM Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Pril-series Intermediate Product Profiles, Application and Specification

3.18.3 LGM Pharma Pril-series Intermediate Market Performance (2014-2019)

3.18.4 LGM Pharma Business Overview

3.19 Canagen Pharmaceuticals Inc

3.19.1 Canagen Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Pril-series Intermediate Product Profiles, Application and Specification

3.19.3 Canagen Pharmaceuticals Inc Pril-series Intermediate Market Performance (2014-2019)

3.19.4 Canagen Pharmaceuticals Inc Business Overview

3.20 Shasun Chemicals and Drugs Ltd

3.20.1 Shasun Chemicals and Drugs Ltd Basic Information, Manufacturing Base, Sales Area and Competitors

3.20.2 Pril-series Intermediate Product Profiles, Application and Specification

3.20.3 Shasun Chemicals and Drugs Ltd Pril-series Intermediate Market Performance (2014-2019)

3.20.4 Shasun Chemicals and Drugs Ltd Business Overview

3.21 Jiangsu Wisdom Pharmaceutical

3.21.1 Jiangsu Wisdom Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.21.2 Pril-series Intermediate Product Profiles, Application and Specification

3.21.3 Jiangsu Wisdom Pharmaceutical Pril-series Intermediate Market Performance (2014-2019)

3.21.4 Jiangsu Wisdom Pharmaceutical Business Overview

3.22 Genesisny

3.22.1 Genesisny Basic Information, Manufacturing Base, Sales Area and Competitors

3.22.2 Pril-series Intermediate Product Profiles, Application and Specification

3.22.3 Genesisny Pril-series Intermediate Market Performance (2014-2019)

3.22.4 Genesisny Business Overview

3.23 Hemofarm

3.23.1 Hemofarm Basic Information, Manufacturing Base, Sales Area and Competitors

3.23.2 Pril-series Intermediate Product Profiles, Application and Specification

3.23.3 Hemofarm Pril-series Intermediate Market Performance (2014-2019)

3.23.4 Hemofarm Business Overview

3.24 Sun Pharma

3.24.1 Sun Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.24.2 Pril-series Intermediate Product Profiles, Application and Specification

3.24.3 Sun Pharma Pril-series Intermediate Market Performance (2014-2019)

3.24.4 Sun Pharma Business Overview

3.25 Signa S.A. de C.V.

3.25.1 Signa S.A. de C.V. Basic Information, Manufacturing Base, Sales Area and Competitors

3.25.2 Pril-series Intermediate Product Profiles, Application and Specification

3.25.3 Signa S.A. de C.V. Pril-series Intermediate Market Performance (2014-2019)

3.25.4 Signa S.A. de C.V. Business Overview

3.26 Farmhispania

3.26.1 Farmhispania Basic Information, Manufacturing Base, Sales Area and Competitors

3.26.2 Pril-series Intermediate Product Profiles, Application and Specification

3.26.3 Farmhispania Pril-series Intermediate Market Performance (2014-2019)

3.26.4 Farmhispania Business Overview

3.27 King Pharmaceuticals

3.27.1 King Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.27.2 Pril-series Intermediate Product Profiles, Application and Specification

3.27.3 King Pharmaceuticals Pril-series Intermediate Market Performance (2014-2019)

3.27.4 King Pharmaceuticals Business Overview

3.28 Aarti Industries Ltd

3.28.1 Aarti Industries Ltd Basic Information, Manufacturing Base, Sales Area and Competitors

3.28.2 Pril-series Intermediate Product Profiles, Application and Specification

3.28.3 Aarti Industries Ltd Pril-series Intermediate Market Performance (2014-2019)

3.28.4 Aarti Industries Ltd Business Overview

4 Global Pril-series Intermediate Production, Revenue (Value), Price Trend by Type

4.1 Global Pril-series Intermediate Production and Market Share by Type (2014-2019)

4.2 Global Pril-series Intermediate Revenue and Market Share by Type (2014-2019)

4.3 Global Pril-series Intermediate Price by Type (2014-2019)

4.4 Global Pril-series Intermediate Production Growth Rate by Type (2014-2019)

4.4.1 Global Pril-series Intermediate Production Growth Rate of Benazepril (2014-2019)

4.4.2 Global Pril-series Intermediate Production Growth Rate of Cilazapril (2014-2019)

4.4.3 Global Pril-series Intermediate Production Growth Rate of Quinapril (2014-2019)

4.4.4 Global Pril-series Intermediate Production Growth Rate of Ramipril (2014-2019)

5 Global Pril-series Intermediate Market Analysis by Application

5.1 Global Pril-series Intermediate Consumption and Market Share by Application (2014-2019)

5.2 Global Pril-series Intermediate Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Pril-series Intermediate Consumption Growth Rate of Table (2014-2019)

5.2.2 Global Pril-series Intermediate Consumption Growth Rate of Capsule (2014-2019)

5.2.3 Global Pril-series Intermediate Consumption Growth Rate of Others (2014-2019)

6 Global Pril-series Intermediate Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Pril-series Intermediate Consumption by Region (2014-2019)

6.2 United States Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.3 Europe Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.4 China Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.5 Japan Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.6 India Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

7 Global Pril-series Intermediate Production, Revenue (Value) by Region (2014-2019)

7.1 Global Pril-series Intermediate Production and Market Share by Region (2014-2019)

7.2 Global Pril-series Intermediate Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

8 Pril-series Intermediate Manufacturing Analysis

8.1 Pril-series Intermediate Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Pril-series Intermediate

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Pril-series Intermediate Industrial Chain Analysis

9.2 Raw Materials Sources of Pril-series Intermediate Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Pril-series Intermediate

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Pril-series Intermediate Market Forecast (2019-2026)

11.1 Global Pril-series Intermediate Production, Revenue Forecast (2019-2026)

11.1.1 Global Pril-series Intermediate Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Pril-series Intermediate Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Pril-series Intermediate Price and Trend Forecast (2019-2026)

11.2 Global Pril-series Intermediate Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Pril-series Intermediate Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Pril-series Intermediate Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Pril-series Intermediate Product Picture

Table Global Pril-series Intermediate Production and CAGR (%) Comparison by Type

Table Profile of Benazepril

Table Profile of Cilazapril

Table Profile of Quinapril

Table Profile of Ramipril

Table Pril-series Intermediate Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Table

Table Profile of Capsule

Table Profile of Others

Figure Global Pril-series Intermediate Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Europe Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Germany Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure UK Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure France Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Italy Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Spain Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Russia Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Poland Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure China Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Japan Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure India Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Malaysia Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Singapore Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Philippines Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Indonesia Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Thailand Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Vietnam Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Central and South America Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Brazil Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Mexico Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Colombia Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Turkey Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Egypt Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure South Africa Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Nigeria Pril-series Intermediate Revenue and Growth Rate (2014-2026)

Figure Global Pril-series Intermediate Production Status and Outlook (2014-2026)

Table Global Pril-series Intermediate Production by Player (2014-2019)

Table Global Pril-series Intermediate Production Share by Player (2014-2019)

Figure Global Pril-series Intermediate Production Share by Player in 2018

Table Pril-series Intermediate Revenue by Player (2014-2019)

Table Pril-series Intermediate Revenue Market Share by Player (2014-2019)

Table Pril-series Intermediate Price by Player (2014-2019)

Table Pril-series Intermediate Manufacturing Base Distribution and Sales Area by Player

Table Pril-series Intermediate Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Esteve Quimica Profile

Table Esteve Quimica Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Cemelog-BRS Profile

Table Cemelog-BRS Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Arrow Pharmaceuticals Profile

Table Arrow Pharmaceuticals Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Strides Shasun Limited Profile

Table Strides Shasun Limited Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Pharmanova Profile

Table Pharmanova Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Lek Profile

Table Lek Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Aurobindo Pharma Limited Profile

Table Aurobindo Pharma Limited Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Sanofi-Aventis Profile

Table Sanofi-Aventis Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Zhejiang Huahai Pharmaceutical Co., Ltd. Profile

Table Zhejiang Huahai Pharmaceutical Co., Ltd. Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Westfield Pharma Profile

Table Westfield Pharma Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Santa Cruz Biotechnology Profile

Table Santa Cruz Biotechnology Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Opsonin Pharma Limited Profile

Table Opsonin Pharma Limited Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table ScinoPharm Taiwan Profile

Table ScinoPharm Taiwan Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Mylan LLC Profile

Table Mylan LLC Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Primetime Profile

Table Primetime Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis Profile

Table Novartis Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Lupin Ltd Profile

Table Lupin Ltd Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table LGM Pharma Profile

Table LGM Pharma Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Canagen Pharmaceuticals Inc Profile

Table Canagen Pharmaceuticals Inc Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Shasun Chemicals and Drugs Ltd Profile

Table Shasun Chemicals and Drugs Ltd Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Jiangsu Wisdom Pharmaceutical Profile

Table Jiangsu Wisdom Pharmaceutical Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Genesisny Profile

Table Genesisny Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Hemofarm Profile

Table Hemofarm Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Sun Pharma Profile

Table Sun Pharma Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Signa S.A. de C.V. Profile

Table Signa S.A. de C.V. Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Farmhispania Profile

Table Farmhispania Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table King Pharmaceuticals Profile

Table King Pharmaceuticals Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Aarti Industries Ltd Profile

Table Aarti Industries Ltd Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Pril-series Intermediate Production by Type (2014-2019)

Table Global Pril-series Intermediate Production Market Share by Type (2014-2019)

Figure Global Pril-series Intermediate Production Market Share by Type in 2018

Table Global Pril-series Intermediate Revenue by Type (2014-2019)

Table Global Pril-series Intermediate Revenue Market Share by Type (2014-2019)

Figure Global Pril-series Intermediate Revenue Market Share by Type in 2018

Table Pril-series Intermediate Price by Type (2014-2019)

Figure Global Pril-series Intermediate Production Growth Rate of Benazepril (2014-2019)

Figure Global Pril-series Intermediate Production Growth Rate of Cilazapril (2014-2019)

Figure Global Pril-series Intermediate Production Growth Rate of Quinapril (2014-2019)

Figure Global Pril-series Intermediate Production Growth Rate of Ramipril (2014-2019)

Table Global Pril-series Intermediate Consumption by Application (2014-2019)

Table Global Pril-series Intermediate Consumption Market Share by Application (2014-2019)

Table Global Pril-series Intermediate Consumption of Table (2014-2019)

Table Global Pril-series Intermediate Consumption of Capsule (2014-2019)

Table Global Pril-series Intermediate Consumption of Others (2014-2019)

Table Global Pril-series Intermediate Consumption by Region (2014-2019)

Table Global Pril-series Intermediate Consumption Market Share by Region (2014-2019)

Table United States Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table Europe Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table China Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table Japan Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table India Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table Central and South America Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Pril-series Intermediate Production, Consumption, Export, Import (2014-2019)

Table Global Pril-series Intermediate Production by Region (2014-2019)

Table Global Pril-series Intermediate Production Market Share by Region (2014-2019)

Figure Global Pril-series Intermediate Production Market Share by Region (2014-2019)

Figure Global Pril-series Intermediate Production Market Share by Region in 2018

Table Global Pril-series Intermediate Revenue by Region (2014-2019)

Table Global Pril-series Intermediate Revenue Market Share by Region (2014-2019)

Figure Global Pril-series Intermediate Revenue Market Share by Region (2014-2019)

Figure Global Pril-series Intermediate Revenue Market Share by Region in 2018

Table Global Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table China Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table India Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Pril-series Intermediate Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Pril-series Intermediate

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Pril-series Intermediate

Figure Pril-series Intermediate Industrial Chain Analysis

Table Raw Materials Sources of Pril-series Intermediate Major Players in 2018

Table Downstream Buyers

Figure Global Pril-series Intermediate Production and Growth Rate Forecast (2019-2026)

Figure Global Pril-series Intermediate Revenue and Growth Rate Forecast (2019-2026)

Figure Global Pril-series Intermediate Price and Trend Forecast (2019-2026)

Table United States Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Pril-series Intermediate Production, Consumption, Export and Import Forecast (2019-2026)

Table China Pril-se

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370